Suppliers / Tianjin Pharmaceutical Holdings Gencom Pharmacy

Tianjin Pharmaceutical Holdings Gencom Pharmacy

China Updated 9 July 2026

Tianjin Pharmaceutical Holdings Gencom Pharmacy is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 4 molecules.

4
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Cefdinir US FDA 1
Flavin Mononucleotide US FDA 1
Glyburide US FDA 1
Repaglinide US FDA 1

Also appears on these molecule pages

Questions about Tianjin Pharmaceutical Holdings Gencom Pharmacy

Does Tianjin Pharmaceutical Holdings Gencom Pharmacy hold a US DMF or a CEP?
Tianjin Pharmaceutical Holdings Gencom Pharmacy holds 4 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Tianjin Pharmaceutical Holdings Gencom Pharmacy make?
4 molecules are on record against Tianjin Pharmaceutical Holdings Gencom Pharmacy, including Cefdinir, Flavin Mononucleotide, Glyburide and Repaglinide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Tianjin Pharmaceutical Holdings Gencom Pharmacy comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability